Peripheral Artery Disease Market to Register Incremental Growth by 2032, Asserts DelveInsight | Key Companies – Otsuka, Helixmith, Daiichi Sankyo, Bayer, Janssen, Rexgenero, Reven Pharma, and Others

 Breaking News
  • No posts were found

Peripheral Artery Disease Market to Register Incremental Growth by 2032, Asserts DelveInsight | Key Companies – Otsuka, Helixmith, Daiichi Sankyo, Bayer, Janssen, Rexgenero, Reven Pharma, and Others

May 02
20:35 2022
Peripheral Artery Disease Market to Register Incremental Growth by 2032, Asserts DelveInsight | Key Companies - Otsuka, Helixmith, Daiichi Sankyo, Bayer, Janssen, Rexgenero, Reven Pharma, and Others
Delveinsight Business Research LLP
DelveInsight’s “Peripheral Artery Disease Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Peripheral Artery Disease Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Peripheral Artery Disease market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Peripheral Artery Disease Market

Peripheral Artery Disease: An Overview

Peripheral Artery Disease (also called peripheral arterial disease) is a common circulatory problem in which narrowed arteries reduce blood flow to the limbs. When a patient develops PAD, then the extremities — usually the legs — do not receive enough blood flow to keep up with demand. This causes symptoms, most notably leg pain when walking (claudication).

Peripheral artery disease is also likely to be a sign of a more widespread accumulation of fatty deposits in the arteries (atherosclerosis). This condition may be reducing blood flow to the heart and brain, as well as the legs. Patients often can successfully treat peripheral artery disease by quitting tobacco, exercising, and eating a healthy diet. 

Peripheral Artery Disease Market Key Facts

  • According to a study conducted by Alzamora et al. titled “The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population,” the prevalence of peripheral arterial disease was 7.6% (6.7–8.4), (males 10.2%, females 5.3%). The prevalence of the peripheral arterial disease is low, higher in males, and increases with age in both sexes.

  • According to the study by Shu et al titled “Update on peripheral artery disease: Epidemiology and evidence-based facts,” it is estimated that >200 million people have PAD worldwide, with a spectrum of symptoms from none to severe.

Peripheral Artery Disease Market

As per DelveInsight, the Peripheral Artery Disease (PAD) market size is expected to increase during the forecast period owing to the launch of upcoming therapies. Increasing awareness and changing lifestyles are some other factors that will drive the growth of the Peripheral Artery Disease market in the 7MM Region.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Peripheral Artery Disease market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Peripheral Artery Disease market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Peripheral Artery Disease Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Peripheral Artery Disease (PAD) Epidemiology Subtype Segmentation – 

  • Prevalent Population of PAD

  • Gender-specific Cases of PAD

  • Diagnosed Cases of PAD

  • Treatable Cases of PAD

Peripheral Artery Disease Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Peripheral Artery Disease market or expected to get launched during the study period. The analysis covers Peripheral Artery Disease market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Peripheral Artery Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Peripheral Artery Disease Therapeutics Analysis

The Peripheral Artery Disease market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies and incremental healthcare spending across the world.

Some of the key companies in the Peripheral Artery Disease (PAD) Market include:

  • Helixmith

  • Daiichi Sankyo

  • Bayer

  • Janssen

  • Rexgenero Limited

  • Reven Pharmaceuticals 

  • Bristol Meyers Squib

  • Otsuka America Pharmaceutical

And many others.

Peripheral Artery Disease (PAD) Therapies covered in the report include:

  • Plavix

  • Xarelto

  • Pletal

  • VM202

  • REX-001

  • Edoxaban

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Peripheral Artery Disease Competitive Intelligence Analysis

4. Peripheral Artery Disease Market Overview at a Glance

5. Peripheral Artery Disease Disease Background and Overview

6. Peripheral Artery Disease Patient Journey

7. Peripheral Artery Disease Epidemiology and Patient Population

8. Peripheral Artery Disease Treatment Algorithm, Current Treatment, and Medical Practices

9. Peripheral Artery Disease Unmet Needs

10. Key Endpoints of Peripheral Artery Disease Treatment

11. Peripheral Artery Disease Marketed Products

12. Peripheral Artery Disease Emerging Therapies

13. Peripheral Artery Disease Seven Major Market Analysis

14. Attribute Analysis

15. Peripheral Artery Disease Market Outlook (7 major markets)

16. Peripheral Artery Disease Access and Reimbursement Overview

17. KOL Views on the Peripheral Artery Disease Market.

18. Peripheral Artery Disease Market Drivers

19. Peripheral Artery Disease Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Other Latest Reports By DelveInsight

Spine Biologics Market

The global Spine Biologics/Orthobiologics Market was valued at USD 5.33 billion in 2020, growing at a CAGR of 4.44% during the forecast period from 2021 to 2026, it is expected to reach USD 6.84 billion by 2026. Some of the key companies in the Spine Biologics Market include Medtronic, Stryker, Collagen Matrix, Inc., Arthrex, Bioventus, Sanofi, Seikagaku Corporation, DePuy Synthes (Johnson & Johnson), Globus Medical, Zimmer Biomet, NuVasive, SeaSpine, Baxter, Exactech, RTI Surgical, Biomatlante, Fidia Farmaceutici, LG Chem, TERUMO BCT, Anika Therapeutics, Orthofix Medical, Kuros Biosciences, XTANT MEDICAL, APTISSEN, BONESUPPORT AB, and others.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

Related Articles


July 2022